Epsilon Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 10-07-2024
- Paid Up Capital ₹ 1.00 M
as on 10-07-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -42.77%
(FY 2019)
- Profit -206.87%
(FY 2019)
- Ebitda 3.53%
(FY 2019)
- Net Worth -8.79%
(FY 2019)
- Total Assets -6.35%
(FY 2019)
About Epsilon Clinical Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mukunda Kumbla and Meghna Mukund serve as directors at the Company.
- CIN/LLPIN
U85110KA2010PTC052726
- Company No.
052726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Epsilon Clinical Research Private Limited offer?
Epsilon Clinical Research Private Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Architectural & Civil Engineering, Architectural Services, Electrical Testing Service, Condition Monitoring Service, Corporate and Soft Skills Training, Corporate Training, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Epsilon Clinical Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukunda Kumbla  | Managing Director | 26-Feb-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meghna Mukund | Director | 18-Oct-2021 | Current |
Financial Performance of Epsilon Clinical Research.
Epsilon Clinical Research Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 42.77% decrease. The company also saw a substantial fall in profitability, with a 206.87% decrease in profit. The company's net worth dipped by a decrease of 8.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Epsilon Clinical Research?
In 2017, Epsilon Clinical Research had a promoter holding of 45.00% and a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balmatta Diagnostic And Research Centre LimitedActive 29 years 10 monthsMukunda Kumbla is a mutual person
- Mangalore Heart Scan And Ct Angio Centre Private LimitedActive 18 years 7 months
Mukunda Kumbla and Meghna Mukund are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Epsilon Clinical Research?
Epsilon Clinical Research has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epsilon Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epsilon Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
